Calmare Therapeutics makes the most of intellectual property (IP) assets. CTI has successfully licensed more than 500 technologies to over 400 individual organizations. CTI approaches customers with an understanding of the client's technology and its market, together with a detailed understanding of the customer's business and the value the client's technology offers the customer.
CTI forms partnerships with its clients and customers to maximize their IP assets, decrease time-to-market and add to their profitability. Calmare Therapeutics unlocks the potential of innovation.